Patruno, IlariaThompson, DawnDall'angelo, SergioWindhorst, Albert D.Vugts, Danielle J.Poot, Alex J.Mody, NimeshZanda, Matteo2021-07-082021-07-082020-08-19Patruno, I, Thompson, D, Dall'angelo, S, Windhorst, A D, Vugts, D J, Poot, A J, Mody, N & Zanda, M 2020, 'Design, synthesis, radiosynthesis and biological evaluation of Fenretinide analogues as anticancer and metabolic syndromepreventive agents', ChemMedChem, vol. 15, no. 16, pp. 1579-1590. https://doi.org/10.1002/cmdc.2020001431860-7179ORCID: /0000-0003-0948-9458/work/77366274ORCID: /0000-0002-2215-7952/work/147568357ORCID: /0000-0001-9377-0474/work/176747551https://hdl.handle.net/2164/16797We thank the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement N° 675417 (PET3D project) for financial support of the project and the studentship of I.P. We also thank the British Heart Foundation for the project grant PG/16/90/32518.121374997engSDG 3 - Good Health and Well-beingretinoic acidClick chemistrycancerfluorine-18diabetesmetabolic syndromeradiopharmaceuticalsR MedicineDrug DiscoveryMolecular MedicineBiochemistryPharmacology, Toxicology and Pharmaceutics(all)PharmacologyOrganic ChemistryBritish Heart FoundationPG/16/90/32518European CommissionN° 675417 (PET3D project)Supplementary DataRDesign, synthesis, radiosynthesis and biological evaluation of Fenretinide analogues as anticancer and metabolic syndromepreventive agentsJournal article10.1002/cmdc.202000143http://www.scopus.com/inward/record.url?scp=85087726706&partnerID=8YFLogxK1516